Justifying conflicts of interest in medical journals: a very bad idea

The former editors of the New England Journal of Medicine nail it. Pharma has taken over the journal and now its editor, Jeffrey Drazen, operates under its dictates. In the future, the former New England Journal of Medicine (NEJM) will in my mind be renamed "The New England Journal of Pharma." This is really sad. I have been a religious follower of the NEJM since the late 1960s. I will continue to follow it as a probable source of misleading information.